USPSTF Recommends Providing Interventions to Support Breastfeeding

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 22, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 22, 2024 -- The U.S. Preventive Services Task Force (USPSTF) recommends providing or referring to interventions that support breastfeeding. This recommendation forms the basis of a draft recommendation statement published online Oct. 22.

Researchers from the Agency for Healthcare Research and Quality in Rockville, Maryland, conducted a systematic review to aid the USPSTF in updating its 2016 recommendation on interventions to support breastfeeding. A total of 290 full-text articles were reviewed for inclusion; 90 randomized clinical trials assessing interventions to support breastfeeding that were initiated in, feasible for, or referable from a primary care setting were included. The researchers found mixed evidence on the effectiveness of breastfeeding support interventions on infant health outcomes, including gastrointestinal outcomes, otitis media, and the number of health care visits for respiratory tract illnesses. More favorable effects were seen in infants born in intervention versus control groups, but few differences were statistically significant. Most of the studies on maternal health outcomes reported better symptom scores among intervention versus control mothers, but differences were not statistically significant. Breastfeeding support interventions were associated with higher rates of any and exclusive breastfeeding at all time points (less than three months, three to less than six months, and six months).

Based on these findings, the USPSTF recommends providing or referring to interventions that support breastfeeding for pregnant and postpartum persons (B recommendation).

The draft evidence review and draft recommendation statement have been posted for public comment. Comments can be submitted from Oct. 22 to Nov. 18, 2024.

Draft Evidence Review

Draft Recommendation Statement

Comment on Recommendation Statement

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords